Median Nerve Injury After Removal of Subdermal Implantable Contraceptive
نویسندگان
چکیده
منابع مشابه
Subdermal contraceptive implants
Subdermal contraceptive implants are an additional approach to meeting the world-wide need for more effective and acceptable birth control. They provide long-acting, highly effective and reversible contraception by achieving low and stable concentrations of synthetic progestogens and require little user compliance, thereby achieving user failure rates that are similar to the method failure rate...
متن کاملUnintended Pregnancy with Implantable Subdermal Contraceptive Device (Nexplanon): A Case Report
Implanon, an Etonogestrel capsule, containing 68 mg of the synthetic progestin etonogestrel implant, was first introduced in Indonesia in 1998 and approved for use in the U.S. in 2006, as a subcutaneous hormone eluting capsule providing longacting reversible contraception (LARC) [1-4]. Prior to the use of Implanon, short-acting reversible contraceptives (SARC) such as oral contraceptive pills (...
متن کاملFat atrophy at the site of a subdermal contraceptive implant.
©FFPRHC J Fam Plann Reprod Health Care 2007: 33(2) Background Progestogen-only implantable contraceptives are an increasingly popular method of contraception used by women worldwide. The implants are inserted subdermally into the arm and slowly release synthetic progesterone into the systemic circulation to prevent pregnancy. Over the years, in response to well-publicised side effect profiles, ...
متن کاملMethods of accurate localisation of non-palpable subdermal contraceptive implants.
©FSRH J Fam Plann Reprod Health Care 2008: 34(1) Introduction Implanon® (Organon International, Oss, The Netherlands) is a single rod, subdermal contraceptive implant system designed to release the progestogen etonogestrel at a near constant rate over 3 years.1,2 This system entered the market in The Netherlands in 1998, and soon after in many other countries in Europe and Asia. It is now marke...
متن کاملClinical experience and acceptability of the etonogestrel subdermal contraceptive implant.
OBJECTIVE To evaluate efficacy, adverse effects, and user continuation rate of an etonogestrel subdermal single-rod contraceptive implant. METHODS A total of 417 healthy volunteers of childbearing age were included in this multicenter trial. After implant insertion, the women were followed up during the 3 years of contraceptive action. At each visit, clinical findings, side effects, and bleed...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: HAND
سال: 2017
ISSN: 1558-9447,1558-9455
DOI: 10.1177/1558944717744335